Stockholders' Equity

3 Months Ended

Jan. 02, 2026

Stockholders' Equity Note [Abstract]

STOCKHOLDERS’ EQUITY

10.    STOCKHOLDERS’ EQUITY

Stock Repurchase and Retirement

On February 4, 2025, the Board of Directors approved a stock repurchase program, pursuant to which the Company is authorized to repurchase up to $2.0 billion of its common stock from time to time through February 3, 2027, on the open market or in privately negotiated transactions, in compliance with applicable securities laws and other legal requirements. The timing and amount of any shares of the Company’s common stock that are repurchased under the stock repurchase program will be determined by the Company’s management based on its evaluation of market conditions and other factors. The stock repurchase program may be suspended or discontinued at any time. The Company currently expects to fund the stock repurchase program using the Company’s working capital.

During each of the three months ended January 2, 2026 and December 27, 2024, the Company did not repurchase any shares of its common stock. As of January 2, 2026, approximately $1.2 billion remained available under the stock repurchase program.

Dividends

On February 3, 2026, the Company announced that the Board of Directors had declared a cash dividend on the Company’s common stock of $0.71 per share. This dividend is payable on March 17, 2026, to the Company’s stockholders of record as of the close of business on February 24, 2026. Future dividends are subject to declaration by the Board of Directors.

Dividends charged to retained earnings were as follows (in millions, except per share data):

	Fiscal Years Ended
	October 2, 2026				October 3, 2025
	Per Share		Total Amount		Per Share		Total Amount
First quarter	$	0.71	$	106.4	$	0.70	$	112.5

Share-based Compensation

The following table summarizes the share-based compensation expense by line item in the Consolidated Statements of Operations (in millions):

	Three Months Ended
	January 2, 2026		December 27, 2024
Cost of goods sold	$	17.4	$	7.3
Research and development	29.9		25.6
Selling, general, and administrative	10.4		18.2
Total share-based compensation	$	57.7	$	51.1